Literature DB >> 15985083

Bladder-sparing surgery and continent urinary diversion using the appendix (Mitrofanoff procedure) for urethral cancer.

Mizuki Kobayashi1, Masayoshi Nomura, Yoji Yamada, Naohiro Fujimoto, Tetsuro Matsumoto.   

Abstract

We performed bladder-sparing surgery and continent urinary diversion in two patients with urethral cancer. The first patient was a 58-year-old man with bulbomembranous urethral cancer (squamous cell carcinoma, cT2N0M0). The second patient was a 77-year-old woman with urethral cancer invading the vaginal wall (transitional cell carcinoma with squamous cell carcinoma, cT3N0M0). After bladder-sparing urethrectomy, continent urinary diversion with appendicovesicostomy (Mitrofanoff procedure) was performed in the both patients. More than 4 years after the surgery, both patients were continent, had no trouble with catheterization, and experienced no recurrence of cancer. Bladder-sparing surgery and urinary diversion based on the Mitrofanoff procedure can be considered for appropriately selected patients with urethral cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15985083     DOI: 10.1111/j.1442-2042.2005.01107.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  Urethral carcinoma: critical view on contemporary consecutive series.

Authors:  Leonardo Oliveira Reis; Fábio Ferreira; Murillo Almeida; Ubirajara Ferreira
Journal:  Med Oncol       Date:  2010-07-02       Impact factor: 3.064

Review 2.  A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review.

Authors:  Giuseppe Lucarelli; Marco Spilotros; Antonio Vavallo; Silvano Palazzo; Carlos Miacola; Saverio Forte; Matteo Matera; Marcello Campagna; Ottavio Colamonico; Francesco Schiralli; Francesco Sebastiani; Federica Di Cosmo; Carlo Bettocchi; Giuseppe Di Lorenzo; Carlo Buonerba; Leonardo Vincenti; Giuseppe Ludovico; Pasquale Ditonno; Michele Battaglia
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.